ROC curve analysis revealed that TFF2 achieved AUC values of 0.806 and 0.996, respectively, for differentiating PC from CCA and HCC, significantly outperforming CEA and CA125 (Figures 5E, F). This evidence concerns the gene CEACAM5 and cholangiocarcinoma.